Results 281 to 290 of about 368,214 (310)

Mechanism-Based Inactivation of CYP3A by HIV Protease Inhibitors

Journal of Pharmacology and Experimental Therapeutics, 2005
C. Ernest, S. Hall, David R. Jones
semanticscholar   +1 more source

Protease Inhibitors as Inhibitors of Human Cytochromes P450: High Risk Associated with Ritonavir

Journal of clinical pharmacology, 1998
L. Moltke, D. Greenblatt, J. Grassi, B. W. Granda, S. Duan, S. Fogelman, J. Daily, J. Harmatz, R. Shader   +8 more
semanticscholar   +1 more source

Risk of ovarian function recovery should be considered when switching from treatment with adjuvant tamoxifen to aromatase inhibitor therapy in women with chemotherapy-induced amenorrhea

Ca-A Cancer Journal for Clinicians, 2018
Clement Chung
exaly  

NTRK fusion-positive cancers and TRK inhibitor therapy

Nature Reviews Clinical Oncology, 2018
Emiliano Cocco, Maurizio Scaltriti, Alexander Drilon   +2 more
exaly  

Camostat Attenuates Airway Epithelial Sodium Channel Function in Vivo through the Inhibition of a Channel-Activating Protease

Journal of Pharmacology and Experimental Therapeutics, 2009
Kevin J Coote, H. Atherton-Watson, Rosemary Sugar, A. Young, Andrea MacKenzie-Beevor, M. Gosling, G. Bhalay, G. Bloomfield, Andrew R Dunstan, R. Bridges, J. Sabater, W. Abraham, D. Tully, Ray Pacoma, A. Schumacher, L. HarrisJennifer, H. Danahay   +16 more
semanticscholar   +1 more source

The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy

Nature Reviews Cancer, 2019
Jonathan J Havel, Diego Chowell, Timothy A Chan   +2 more
exaly  

An RNA vaccine drives immunity in checkpoint-inhibitor-treated melanoma

Nature, 2020
Ugur Sahin, Petra Oehm, Mathias Vormehr
exaly  

Endoplasmic Reticulum Stress Links Dyslipidemia to Inhibition of Proteasome Activity and Glucose Transport by HIV Protease Inhibitors

Molecular Pharmacology, 2005
R. Parker, O. Flint, R. Mulvey, Carolina Elosua, Faye Wang, W. Fenderson, Shulin Wang, Wen-pin Yang, Mustafa A. Noor   +8 more
semanticscholar   +1 more source

Appraising iniparib, the PARP inhibitor that never was—what must we learn?

Nature Reviews Clinical Oncology, 2013
Joaquin Mateo, Michael Ong, David S P Tan   +2 more
exaly  

HIV Protease Inhibitors Activate the Unfolded Protein Response in Macrophages: Implication for Atherosclerosis and Cardiovascular Disease

Molecular Pharmacology, 2005
Huiping Zhou, W. Pandak, V. Lyall, R. Natarajan, P. Hylemon   +4 more
semanticscholar   +1 more source